Download Complimentary Report Summary

Allocate Late-Stage Budgets for Global Launch

Align dollars and people for a winning drug launch. With spending and staffing data for the commercialization of 16 brands, this report analyzes launches across the industry - including niche products with modest budgets, mid-level products balancing expenditures and larger brands with blockbuster hopes.

The report breaks down brands' commercialization spending and headcounts into three time segments and four spending categories:

Time Segments

• Phase III
• Registration and launch
• First 12-18 months on market
• For Pre-Clinical to Phase II data, visit PharmaCommercialization.com)

Spending Categories

• Brand activities
• Market research
• Thought leader development
• Advertising

The commercialization of new drugs continues to challenge companies across the pharmaceutical and biotechnology sectors. This report provides valuable assistance to individuals and teams who seek guidance in the allocation of pre- and post-launch marketing resources.

Call Adam Bianchi  at 919-403-6583 to get your own copy of "Global Drug Launches" today.